Marcy l'Étoile (France), April 20, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2017.
Asia
Europe, Middle East, Africa
North America
bioMérieux – First-Quarter 2017 Business Review
20 April, 2017
bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system
06 April, 2017
Marcy l’Étoile (France) - April 6, 2017 – bioMérieux, a major player in the field of in vitro diagnostics, and the world leader in microbiology, announces that BacT/ALERT® VIRTUO™, its fully automated blood culture system, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Spring Holiday Shipping Schedule 2017
03 April, 2017
Please be advised that bioMérieux Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed on Friday, April 14 in observance of the upcoming holiday.
bioMérieux Opens New Production Line at Durham Facility, Expanding Capacity of BacT/ALERT® Blood Culturing Bottles Vital in Fight Against Resistant Infections
31 March, 2017
Durham, NC – March 29, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce the opening of a new production line at its Americas Headquarters in Durham, North Carolina.
bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis
24 February, 2017
bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S PCT™, an automated assay measuring procalcitonin (PCT) levels, to help clinicians make important decisions regarding the optimal use of antibiotics in two common clinical situations: lower respiratory tract infections (LRTI) and sepsis.
bioMérieux – Fourth-Quarter 2016 Business Review
19 January, 2017
Marcy l'Étoile, January 19, 2017 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the twelve months ended December 31, 2016.
bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury
19 January, 2017
bioMérieux, a world leader in the field of in vitro diagnostics and Banyan Biomarkers, an innovative biomarkers company developing blood tests capable of diagnosing traumatic brain injuries (TBI), announced today that they have entered into a partnership.
Year End Holiday Shipping Schedule
15 November, 2016
Please be advised that bioMérieux sites in Durham, St. Louis, Louisville and Lombard will be closed on Thursday, November 24 and Friday, November 25 as well as Monday, December 26 and Tuesday, December 27 in observance of the upcoming holidays.
Veteran's Day Shipping Schedule
03 November, 2016
As part of our commitment to providing you more efficient and better services we will be upgrading our ERP system, SAP, on Friday, November 11, 2016.
bioMérieux – Business Review for the nine months ended September 30, 2016
20 October, 2016
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2016.